Scalper1 News
Specialty drugmaker Horizon Pharma (HZNP) beat analysts’ Q1 estimates and raised its sales guidance Friday morning, briefly rallying the stock on the stock market today. Horizon reported its first quarterly profit, excluding one-time items, making 13 cents a share. Analysts had expected it to make only a penny. Net sales totaled $51.9 million, up from just $8.7 million in the year-earlier quarter and topping analysts’ consensus by more than $9 Scalper1 News
Scalper1 News